Assessing the barriers to image‐guided drug delivery

Author:

Lanza Gregory M.1,Moonen Chrit2,Baker James R.3,Chang Esther4,Cheng Zheng5,Grodzinski Piotr6,Ferrara Katherine7,Hynynen Kullervo8,Kelloff Gary6,Lee Yong‐Eun Koo3,Patri Anil K.9,Sept David3,Schnitzer Jan E.10,Wood Bradford J.11,Zhang Miqin12,Zheng Gang8,Farahani Keyvan6

Affiliation:

1. Division of Cardiology, Washington University Medical SchoolSt. LouisMOUSA

2. Image Sciences InstituteUMC UtrechtUtrechtThe Netherlands

3. Division of Allergy and Clinical Immunology, University of MichiganAnn ArborMIUSA

4. Department of OncologyGeorgetown UniversityWashingtonDCUSA

5. Department of RadiologyStanford UniversityStanfordCAUSA

6. NCI Office of Cancer Nanotechnology Research, National Cancer InstituteBethesdaMDUSA

7. Department of BioengineeringUniversity of CaliforniaDavisCAUSA

8. Department of Medical Biophysics, University of TorontoTorontoCanada

9. Nanotechnology Characterization Laboratory, National Cancer Institute‐FredrickFredrickMDUSA

10. Proteogenomics Research Institute for Systems MedicineSan DiegoCAUSA

11. NIH Center for Interventional Oncology, NIH Clinical CenterBethesdaMDUSA

12. Department of Materials Science and Engineering, University of WashingtonSeattleWAUSA

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3